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A number of investigators have isolated stimulatory factors from the liver of many animals, such as rats, mice and dogs [1] . Sharks were one of the most active animals in the ocean and their liver weighed over 70% of their total bowels with strong immunocompetence. We had reported that active peptide from shark liver had significant protective effects on CCl 4 and D-galactosamine induced liver injury in mice [2] and immunoloregulation effect on immune liver injury in mice [3] . For exploring the functions of other active substances in shark livers, we isolated a new peptide S-8300 from shark liver. In the present study, we have reported that administration of S-8300 in CCl 4 intoxicated hepatatoxic mice alters the serum marker enzyme and lipid peroxidation index levels, viz ALT, AST, LDH, SOD, GSH, MDA, and also modulates the levels of IL-2 and hemolysin in immunosuppression mice caused by cyclophosphamide. The hepatoprotective, immunomodulatory and inhibiting of lipid peroxidation activity of S-8300 was also reported. Therefore, the results of this study will be very helpful to recognize the beneficial effects of S-8300 on liver function as well as in regulating immune functions.
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Preparation of S-8300
S-8300 was extracted and purified from healthy squalus mitsukurii. The process of extraction and purification of S-8300 mainly included homogenization, heat treating, centrifugation, ultrafiltration, DEAE-sephadex chromatography, biogel P10 chromatography, FPLC mono Q chromatography and reversed-phase HPLC. It was estimated that the molecular weight of S-8300 was 8 300 by SDS-PAGE [10] .
Animals
The ICR mice weighing 20±2 g were obtained from the Experimental Animal Center of China Pharmaceutical University (Nanjing, China), and guinea pigs weighing 350-400 g were from Experimental Animal Center of Nanjing Medical University (Nanjing, China). All the animals 
Liver injury model induced by CCl 4
Mice were divided into six groups of 10 animals each. Group 1 was administrated with saline (20 mL/kg, i.p.) as a normal control. Group 2 was given CCl 4 /olive oil (1:100 v/v, 5 mL/kg, i.p.) as the treated control group. Group 3 received HGF (3 mg/kg, i.p.) as the standard reference group. Test groups of mice were treated with S-8300 at a dose of 0.3, 1 and 3 mg/kg body weight and injected for four consecutive days, followed by mice administrated CCl 4 /olive oil on d 3.
At the end of the experimental period, all the animals were killed, blood was collected in sterile centrifuge tube and allowed to clot. Serum was separated by centrifuging at 2 500 r/min for 15 min. After the animals were killed, their livers were removed. A part of liver specimens were homogenized in Tris-HCl buffer (0.01 mol/L, pH 7.4) using a homogenizer to give a 10% homogenate, the other liver sections were preserved in 10% neutral formalin, and were processed for paraffin embedding, following the standard microtechnique. Five micron sections of livers, stained with alum hematoxylin and eosin were observed under microscope for the histopathological changes.
Immunosuppression model caused by Cy
Mice were randomly allocated into a normal control group, a model control group, and three doses of S-8300 groups (0.3, 1 and 3 mg/kg) of 10 animals each. The latter four groups were administered with Cy (100 mg/kg) at the beginning of the experiment to induce immunosuppression model. The S-8300 groups were also treated with S-8300 seven days after the beginning of Cy administration. All control groups were given corresponding placebo at the same time. Mice were sensitized by injected 0.2 mL of 20% SRBC under the skin at d 2. At the end of the seven days, 2 h after the S-8300 injection, mice in each group were killed. They were bled and the blood was collected for serum hemolysin test and IL-2 ELISA assay.
Biochemical and enzymatic estimations
The levels of serum ALT, AST, LDH, SOD, IL-2, content of MDA and GSH in liver were determined by using commercial kits according to the guidelines indicated.
Determination of serum hemolysin
Serum hemolysin was determined using Ying et al's method [4] and was measured spectrophotometrically at 540 nm.
Statistical analysis
Data were expressed as mean±SD. Statistical analysis was evaluated by one-way analysis of variance, followed by the Student-Newman-Kanul's test for multiple comparisons which was used to evaluate the difference between two groups. P<0.01 was considered significant.
RESUL RESUL RESUL RESUL RESULTS TS TS TS TS Alters of liver function
Administration of CCl4 to mice caused significant increase in serum marker enzymes like ALT (135.9±6.5 U/dL vs 13.4±2.5 U/dL, P<0.01), AST (238.8±8.7U/dL vs 42.4±10.9 U/dL, P<0.01), LDH (240.4±6.0 U/dL vs 150.3±45.8 U/dL, P<0.01), compared to normal control mice. Treatment with S-8300 caused significant reduction of these values (Table 1) , ALT (52.2±11.0 U/dL vs 135.9±6.5 U/dL, P<0.01), AST (67.5±6.9 U/dL vs 238.8±8.7 U/dL, P<0.01), LDH (155.1±46.8 U/dL vs 240.4±6.0 U/dL, P<0.01), dosedependently. The LDH level was almost restored to the levels found in control and S-8300 3 mg/kg group of mice. Treatment with HGF also reversed the hepatotoxicity significantly. (Table 2) . Treatment with HGF also reversed the lipid peroxidation significantly.
Histological examination
Histological observations basically support the results obtained from serum enzyme assays. The liver of CCl 4 -intoxicated mice showed massive fatty changes, gross necrosis, broad infiltration of lymphocytes and Kupffer cells around the central vein and loss of cellular boundaries. The histological pattern of liver of mice pretreated with S-8300 and subsequently given CCl 4 showed a more or less normal lobular pattern with a mild degree of fatty change, necrosis and lymphocyte infiltration almost comparable to the normal control and HGF groups (Figure 1 ).
Immunomodulatory effect
S-8300 markedly improved the formulation of serum hemolysin (0.094±0.005 A 540 vs 0.063±0.006 A 540 , P<0.01) and increased the lever of IL-2 (9.74±1.16 pg/mL vs 5.81±0.87 pg/mL, P<0.01) in serum of the immunosuppression mice (Table 3) .
DISCUSSION DISCUSSION DISCUSSION DISCUSSION DISCUSSION
Liver tissue rich in both transaminase increased in patients with acute hepatic diseases, AST which is slightly elevated by cardiac necrosis is a more specific indicator of liver disease. In view of this, S-8300 mediated reduction in levels of AST, ALT and LDH towards the respective normal values is an indication of stabilization of plasma membrane as well as repair of hepatic tissue damage caused by CCl 4 [7] . CCl 4 is one of the most commonly used hepatotoxins in the experimental study of liver diseases. It has been established that CCl 4 is accumulated in hepatic parenchyma cells and metabolically activated by cytochrome P450-dependent monooxygenases to form a trichloromethyl radical (CCl 3 ) [8] . These activated radicals bind covalently to A B C D Table 3 Effect of S-8300 on the levels of serum hemolysin and IL-2 in mice treated with Cy the macromolecules and induce peroxidative degradation of membrane lipids of endoplasmic reticulum rich in polyunsaturated fatty acids. This leads to the formation of lipid peroxides. This lipid peroxidative degradation of biomembranes is one of the principal causes of hepatotoxicity of CCl 4 [5] . Thus, antioxidant or free radical generation inhibition is important in protection against CCl 4 -induced liver lesions. The efficacy of any hepatoprotective drug is essentially dependent on its ability to reduce the harmful effects or maintain the normal hepatic physiology that has been disturbed by a hepatotoxin [6] . In the present study, administration of S-8300 not only decreased the CCl 4 induced elevated levels of AST, ALT, LDH and MDA, but also increased levels of SOD and GSH. This suggested the maintenance of structural integrity of hepatocytic cell membrane or regeneration of damaged liver cells by inhibiting lipid peroxidation activity of S-8300. These findings can be further corroborated with histopathological studies. The histopathological examination clearly reveals that the hepatic cells, central vein, and portal triad are almost normal in S-8300 (3 mg/kg, i.p.) group in contrast to group which received CCl 4 . Thus, S-8300 can be considered to be an effective hepatoprotective peptide.
This work also evaluated the influence of S-8300 on activities in the immune system of mice experimentally induced immunosuppression. In the case of cellular immunity, the enhancement of IL-2 concentration in serum induced by S-8300 exerts profound changes in the number and activation degree of monocytes and T cells. In the case of humoral immune response, S-8300 could stimulate the formulation of hemolysin. The immunomodulatory effect of S-8300 on both parameters of cellular immune and humoral immune responses was effectively enhanced. S-8300 thus amplified an immune response.
The present study evaluated the association of liver protection by S-8300 and the modulation of the immune system suspected to be involved in the development of liver dysfunction. Hyperactivity of oxidants is thus equally as dangerous as hypoactivity, which may in turn cause immunosuppression [9] . It could be predicted that S-8300 could serve a beneficial role as an antioxidant, and was capable of removing free radicals from a system either by prolonging the initiation phase or by inhibiting the propagation phase of autooxidation. From our results, it could be suggested that S-8300 would be a good alternative to therapy for hepatitis. It would also scavenge the free radicals in human bodies, and with its immunostimulatory effect it could prevent foreign pathogenic invasion.
